In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Morgan Stanley’s current price exceeds the PERT-weighted fair value by 36.7%, signaling potential overvaluation based on multiple valuation methods, notably the low DCF estimate. Monte Carlo analysis shows significant upside volatility with a median of $314.17 but also a 16.7% downside risk below current price. Financial health scores reveal strong profitability and growth, offset by poor efficiency and leverage, highlighting mixed operational risk factors.